Clinical Trial Update: A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle After Cataract Surgery in Diabetic Retinopathy Patients [Phase 2]

View source ↗

Summary

Phase 2 trial comparing NEVANAC 0.1% to vehicle after cataract surgery in diabetic retinopathy patients, assessing safety and efficacy for macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Diabetic Retinopathy

Drugs mentioned

• NEVANAC 0.1% (nepafenac)

Snippet

Sponsor: Alcon Research | Conditions: Macular Edema | Phase 2 | Status: COMPLETED | Results posted: 2011-09-21